# US 2019/0315801 A1 · Gene encoding alanyl- glutamine dipeptide biosynthetic enzyme and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0315801 A1
- Document ID: US20190315801A1
- Status: Published application
- Kind: A1
- Application number: 16/455,502
- Filed: 2019-06-27
- Published: 2019-10-17
- Earliest claimed: 2016-12-30
- Assignees: Innobio Corporation Limited
- Applicants: Innobio Corporation Limited
- Inventors: Wenjie YUAN; Chao FAN; Yimin LI; Hao HONG; Wenzhong WU
- Web page: https://patentgrep.com/patent/US20190315801A1

## CPC

- C07K 5/06: Dipeptides
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12N 1/16: Yeasts; Culture media therefor
- C12N 1/20: Bacteria; Culture media therefor
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 2500/32: Amino acids
- C12N 2500/34: Sugars
- C12R 2001/19: Escherichia coli
- C12R 2001/865: Saccharomyces cerevisiae
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Provided is a gene encoding alanyl-glutamine dipeptide biosynthetic enzyme and the application thereof. The nucleotide sequence of said gene is shown in SEQ ID NO: 1. Further, provided is an amino acid sequence encoded by the gene, and provided recombinant vector, recombinant E. coli, recombinant S. cerevisiae, and a self-flocculating recombinant S. cerevisiae containing the gene. Furthermore, provided is a method for carrying out bioconversion to synthesize alanyl-glutamine dipeptide by using said recombinant microorganisms. The application of the gene and recombinant batteries has the characteristics of high molar conversion rate, fast production rate and repeated recycling of the bacteria. It is a good choice for efficient, environmentally friendly and economical production of alanyl-glutamine dipeptide. In addition, through the recycling process, it is expected to reduce the cost of industrial production, solve the problems of difficult enzyme recovery, low utilization rate and unstable enzyme activity.

## Claims

### Claim 1

A gene encoding alanyl-glutamine dipeptide biosynthetic enzyme, wherein nucleotide sequence is shown in SEQ ID NO: 1.

### Claim 2 (depends on 1)

An alanyl-glutamine dipeptide biosynthetic enzyme, encoded by the gene of claim 1, wherein amino acid sequence is shown in SEQ ID NO: 2.

### Claim 3 (depends on 1)

A recombinant E. coli. is obtained by transferring a nucleotide sequence of the gene of claim 1 into Escherichia coli.

### Claim 4 (depends on 3)

A biosynthesis method of alanyl-glutamine dipeptide, comprising a step of transforming a substrate using the recombinant E. coli. of claim 3.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the substrate comprises a carboxyl component and an amine component, the carboxyl component is selected from the group consisting of amino acid esters and amino acid amides, the amine component is selected from the group consisting of amino acids, C-protected amino acids and amines.

### Claim 6 (depends on 4)

The method according to claim 4, comprising the following steps:
(1) dissolving the substrate L-alanine methyl ester hydrochloride and L-glutamine in a buffer solution, and adjusting the pH to 8.0-10.0;
(2) adding the recombinant E. coli to a system obtained in step (1) to react, with the reaction temperature of 15 to 40° C., and pH of the reaction system of 8.0 to 10.0;
(3) collecting the reaction solution and centrifuging to separate bacterial cells and terminate the reaction at the reaction end point when pH is not lowered any longer.

### Claim 7 (depends on 6)

The method according to claim 6, further comprising a step of recycling the bacterial cells of recombinant E. coli.

### Claim 8 (depends on 1)

A method for biosynthesizing alanyl-glutamine dipeptide, comprising the following steps:
(1) constructing a recombinant E. coli;
cloning a gene of claim 1, constructing a recombinant vector comprising the gene using the expression vector pET29a, and transforming the recombinant vector into an expression host E. coli BL21 (DE3) by heat shock method;
(2) preserving the positive transformants obtained by the resistance gene screening, PCR and restriction enzyme verification step (1) in a slant medium;
The slant medium: yeast extract powder 5 g/L, tryptone 10 g/L, NaCl 10 g/L, agar powder 20 g/L, sterilized at 121° C. for 15 min, after cooling, adding kanamycin at a final concentration of 10-100 ug/mL;
(3) transferring activated recombinant E. coli to a seed culture medium and performing amplification culture at 37° C., 200 rpm, adding isopropyl thiogalactoside (IPTG) at a final concentration of 0.2 to 2.0 mM overnight to induce culture at a low temperature when cell OD600=0.4 to 1.0;
The seed medium: yeast extract powder 5 g/L, tryptone 10 g/L, NaCl 10 g/L, sterilized at 121° C. for 15 min, after cooling, adding kanamycin at a final concentration of 10-100 ug/mL;
(4) Biosynthesis of alanyl-glutamine dipeptide:
dissolving the substrate L-alanine methyl ester hydrochloride and L-glutamine in a buffer solution, adding the culture of step (3), and adjusting the pH to 8.0-9.0, reacting the system at 25±1° C., until the pH value is no longer lowered as the end point of reaction, and collecting the reaction solution to centrifuge and separate bacterial cells;
(5) adding the bacterial cells obtained in the step (4) to a new reaction system for recycling production of alanyl-glutamine dipeptide.

### Claim 9 (depends on 1)

A recombinant S. cerevisiae, comprising a gene of claim 1.

### Claim 10 (depends on 9)

The recombinant S. cerevisiae according to claim 9, further comprising an exogenous flocculating gene FLO1.

### Claim 11 (depends on 9)

A biosynthesis method of alanyl-glutamine dipeptide, comprising the step of transforming a substrate using the recombinant S. cerevisiae of claim 9.

### Claim 12 (depends on 10)

A biosynthesis method of alanyl-glutamine dipeptide, comprising the step of transforming a substrate using the recombinant S. cerevisiae of claim 10.

### Claim 13 (depends on 11)

The method according to claim 11, wherein the substrate comprises a carboxyl component and an amine component, the carboxyl component is selected from the group consisting of amino acid esters and amino acid amides, the amine component is selected from the group consisting of amino acids, C-protected amino acids and amines.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the substrate comprises a carboxyl component and an amine component, the carboxyl component is selected from the group consisting of amino acid esters and amino acid amides, the amine component is selected from the group consisting of amino acids, C-protected amino acids and amines.

### Claim 15 (depends on 11)

The method according to claim 11, comprising the following steps:
(1) dissolving the substrate L-alanine methyl ester hydrochloride and L-glutamine in a solvent system, and adjusting the pH to 8.0-9.0;
(2) adding the recombinant E. coli to a system obtained in step (1) to react, with the reaction temperature of 10 to 40° C., and pH of the reaction system of 8.0 to 9.0;
(3) collecting the reaction solution and centrifuging to separate bacterial cells and terminate the reaction at the reaction end point when pH is not lowered any longer.

### Claim 16 (depends on 12)

The method according to claim 12, comprising the following steps:
(1) dissolving the substrate L-alanine methyl ester hydrochloride and L-glutamine in a solvent system, and adjusting the pH to 8.0-9.0;
(2) adding the recombinant E. coli to a system obtained in step (1) to react, with the reaction temperature of 10 to 40° C., and pH of the reaction system of 8.0 to 9.0;
(3) collecting the reaction solution and centrifuging to separate bacterial cells and terminate the reaction at the reaction end point when pH is not lowered any longer.

### Claim 17 (depends on 15)

The method according to claim 15, further comprising a step of recycling recombinant S. cerevisiae.

### Claim 18 (depends on 16)

The method according to claim 16, further comprising a step of recycling recombinant S. cerevisiae.

### Claim 19 (depends on 1)

A method for biosynthesizing alanyl-glutamine dipeptide, comprising the following steps:
(1) constructing a recombinant S. cerevisiae;
cloning a gene of claim 1, constructing a recombinant vector comprising the gene using the expression vector Pyd1, and transforming the recombinant vector into E. coli BL21 DH5α by heat shock method;
(2) preserving the transformants obtained by the ampicillin resistance gene screening, PCR and restriction enzyme verification step (1) in a slant medium;
(3) extracting a recombinant expression vector from the transformant obtained in the step (2), and transforming into S. cerevisiae EBY100 competent cells, to obtain positive transformant by deficient type screening. The positive transformant is activated and inoculated into a seed culture medium, and when the bacterial cells are grown to OD620=0.5-5.0, they are transferred to an induction medium to obtain recombinant Saccharomyces cerevisiae;
(4) Biosynthesis of alanyl-glutamine dipeptide: dissolve the substrate L-alanine methyl ester hydrochloride and L-glutamine in a solvent system, add a culture in the step (3) to adjust to pH of 8.0 to 9.0 and react the system at a condition of 20±5° C. until the end point of reactions when the pH value is not lowered any longer, and collect reaction liquid to separate bacterial cells;
(5) adding the bacterial cells obtained in the step (4) to a new reaction system for recycling production of alanyl-glutamine dipeptide.

### Claim 20 (depends on 1)

A method for biosynthesizing alanyl-glutamine dipeptide, comprising the following steps:
(1) constructing a recombinant S. cerevisiae;
cloning a gene of claim 1, constructing a recombinant vector comprising the gene using the expression vector pYD1, and transforming the recombinant vector into E. coli DH5α by heat shocking method;
(2) preserving the transformants obtained by the ampicillin resistance gene screening, PCR and restriction enzyme verification step (1) in a slant medium;
(3) extracting a recombinant expression vector from the transformant obtained in the step (2), and transforming into S. cerevisiae EBY100 competent cells, to obtain positive transformant by deficient type screening, the positive transformant is activated and inoculated into a seed culture medium, and when the bacterial cells are grown to OD620=0.5-5.0, they are transferred to an induction medium to obtain recombinant Saccharomyces cerevisiae;
(4) amplifying a flocculating gene FLO1 having a nucleotide sequence of SEQ ID NO: 8 using a primer pair with a nucleotide sequence of SEQ ID NO: 6/7.
(5) ligating the amplified product obtained in step (4) to the expression vector pRS425-pGK, and transforming the ligated product into E. coli DH5a competent cells, and screening transformants on the LB resistant medium plate and perform verification, to obtain a self-flocculating recombinant vector;
(6) transforming the self-flocculating recombinant vector into the competent cells of the recombinant S. cerevisiae prepared in the step (3), to obtain a recombinant S. cerevisiae with self-flocculating ability by LEU-deficient screening.
(7) Biosynthesis of alanyl-glutamine dipeptide:
dissolving the substrate L-alanine methyl ester hydrochloride and L-glutamine in a solvent system, adding the recombinant S. cerevisiae with self-flocculating ability in step (6), and adjusting the pH to 8.0-9.0, reacting the system at 20±5° C., until the pH value is no longer lowered as the end point of reaction, and collecting the reaction solution to separate bacterial cells;
(8) adding the bacterial cells obtained in the step (7) to a new reaction system for recycling production of alanyl-glutamine dipeptide.
